BridgeBio Pharma, Inc. (BBIO)

78.02 -1.09 (-1.38%) USD  |  NASDAQ  |  Jan 14, 14:46
More

BridgeBio Pharma Other Long Term Liabilities (Quarterly)

Other Long Term Liabilities (Quarterly) Chart

View Other Long Term Liabilities (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Liabilities (Quarterly) Range, Past 5 Years

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Liabilities (Quarterly) Benchmarks

View Other Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade